Ignite Creation Date:
2025-12-24 @ 9:12 PM
Ignite Modification Date:
2025-12-25 @ 7:01 PM
Study NCT ID:
NCT00635804
Status:
COMPLETED
Last Update Posted:
2018-09-05
First Post:
2008-02-28
Is NOT Gene Therapy:
False
Has Adverse Events:
True
Brief Title:
Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of MK-3281 in Healthy and Hepatitis C Infected Male Participants (MK-3281-002)
Sponsor:
Merck Sharp & Dohme LLC
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2008-02-19
Start Date Type:
ACTUAL
Primary Completion Date:
2009-12-22
Primary Completion Date Type:
ACTUAL
Completion Date:
2009-12-22
Completion Date Type:
ACTUAL
First Submit Date:
2008-02-28
First Submit QC Date:
None
Study First Post Date:
2008-03-14
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2016-02-18
Results First Submit QC Date:
None
Results First Post Date:
2016-05-04
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2018-08-06
Last Update Post Date:
2018-09-05
Last Update Post Date Type:
ACTUAL